Alexion stock crashed Friday after officials agreed to review Amgen's challenge to the patents covering Alexion's blockbuster drug, Soliris.
View full coverage on Google NewsAlexion Stock Crashes As Amgen Seeks To Invalidate Soliris Patents - Investor's Business Daily
Read More
Bagikan Berita Ini
0 Response to "Alexion Stock Crashes As Amgen Seeks To Invalidate Soliris Patents - Investor's Business Daily"
Post a Comment